Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
Panbela Therapeutics Inc (PBLA) Q2 2024 Earnings Call Transcript Highlights: Key Financials and Strategic Updates
Panbela Therapeutics Inc (PBLA) reports increased R&D expenses and significant progress in clinical trials amidst a challenging financial landscape. Aug 14, 2024
GuruFocus Research Biotechnology
Mersana Therapeutics Inc (MRSN) Q2 2024 Earnings Call Transcript Highlights: Significant Cost Reductions and Clinical Progress
Mersana Therapeutics Inc (MRSN) reports a substantial decrease in operating expenses and advances in clinical trials, despite a drop in collaboration revenue. Aug 14, 2024
GuruFocus Research Biotechnology
Seres Therapeutics Inc (MCRB) Q2 2024 Earnings Call Transcript Highlights: Strong VOWST Sales Growth and Strategic Asset Sale
Seres Therapeutics Inc (MCRB) reports significant growth in VOWST sales and outlines future plans amid a strategic asset sale to Nestle Health Science. Aug 14, 2024
GuruFocus Research Biotechnology
Fennec Pharmaceuticals Inc (FENC) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Partnerships
Fennec Pharmaceuticals Inc (FENC) reports a 120% increase in net revenue and significant progress in global commercialization efforts. Aug 14, 2024
GuruFocus Research Biotechnology
Acumen Pharmaceuticals Inc (ABOS) Q2 2024 Earnings Call Transcript Highlights: Robust Cash Position and Promising Clinical Progress
Acumen Pharmaceuticals Inc (ABOS) reports strong financials and significant advancements in clinical trials, despite rising R&D and G&A expenses. Aug 14, 2024